Quote:
Originally Posted by Slava
I sold early on Covid, and got back in when things cratered with Covid (only saying this because you’re relating the two). To me, this is different for several reasons. First, we’ve seen mpox before and have experience with this very recently. Second, the economic impact with Covid-19 was direct and obvious at that point if you were paying attention. China was closing factories and shutting down. If you had investments in those directly impacted businesses, you were going to see an impact and it would be notable if not severe! If you weren’t convinced that this was a problem (and I’m not sure how, to be honest, because factories shutting down is drastic), once countries like Italy began shutting down, it became evident that this was a more significant problem. It’s impossible to predict mpox, but those things aren’t happening today, and it doesn’t seem as likely with the current situation.
Those are my thoughts at this point, FWIW.
|
Me too, had the most successful investing year by pulling out in Feb of COVID and then piling back in towards the summer.
This is different. Its not nearly as contagious and the virology is a lot different. Transmission between humans is less efficient compared to COVID-19, often requiring prolonged or close contact. The monkeypox virus is more stable and less prone to mutations that might increase virulence or transmissibility and there are also already vaccines out for mpox.